News | April 22, 2008

New Deficit Reduction Act Compliance Tool Launched

April 23, 2008 - Sentry Data Systems Inc. launched the DRA Tool, a reporting and claims editing module that supports the additional reporting requirements of Section 6002 of the Federal Deficit Reduction Act (DRA).

The DRA Tool is feature of the company’s Sentinel RCM pharmacy revenue cycle management product.

The Federal Deficit Reduction Act (DRA), Section 6002, requires Medicaid participating ambulatory care providers to report the National Drug Code (NDC) when billing for physician-administered medications on Medicaid claims. NDC numbers uniquely identify a pharmaceutical’s vendor, product and trade package size and are maintained by the FDA. The previously unreported NDC is now required on claims submitted to Medicaid in addition to the currently required CPT/HCPCs codes and units.

Sentry's DRA Tool automatically matches the correct 11 digit NDCs with appropriate outpatient procedure codes to allow for uninterrupted claims payment by a state’s Medicaid program. Tracking the 11 Digit NDC provides a new mechanism for individual states to maximize their Medicaid rebates from manufacturers and is financially critical for states and responsible entities, said Sentry.

“Sentinel RCM’s DRA Tool provides hospitals with immediate billing compliance by either electronically editing claims as they are submitted and by providing reports that comply with each state's individual requirements,” said Travis Leonardi RPh., C.P. president and founder of Sentry Data Systems.
Existing Sentinel RCM customers need only contact Sentry for activation.
For more information: www.sentryds.com

Related Content

MRI Metal Artifact Reduction Poses Minimal Thermal Risk to Hip Arthroplasty Implants
News | Magnetic Resonance Imaging (MRI) | May 23, 2019
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
360 Photos | Magnetic Resonance Imaging (MRI) | May 17, 2019
This is a dedicated cardiac Siemens 1.5T MRI system installed at the Baylor Scott White Heart Hospital in Dallas.
Miami Cardiac and Vascular Institute Implements Philips Ingenia Ambition X 1.5T MRI
News | Magnetic Resonance Imaging (MRI) | May 17, 2019
Miami Cardiac & Vascular Institute announced the implementation of Philips’ Ingenia Ambition X 1.5T MR, the world’s...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Magnetic Resonance Imaging (MRI) | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...
Clinical Trial Explores Opening Blood-Brain Barrier in Fight Against Alzheimer's

Vibhor Krishna, M.D., (right) fits David Shorr with a helmet-like device used in a new clinical trial for Alzheimer’s disease at The Ohio State University Wexner Medical Center. The device uses MRI-guided imaging to deliver focused ultrasound to specific areas of the brain to open the blood-brain barrier. Image courtesy of Ohio State University Wexner Medical Center.

News | Focused Ultrasound Therapy | May 09, 2019
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing